Industry Reports

Grünenthal announced that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be…
Read More...

Novo Nordisk announced the expansion of its biopharm business with an agreement to acquire the US and Canadian rights to Macrilen(TM) (macimorelin), the first and only FDA-approved oral…
Read More...

Two Labs announced it has acquired Pennside Partners Ltd., an international provider of market insights, benchmarking and competitive intelligence services for the pharmaceutical,…
Read More...

FSD Pharma Inc. announced the signing of a binding letter of intent (the “LOI”) to acquire Therapix Biosciences Ltd. effective October 22, 2018. The Transaction (the “Transaction”)…
Read More...

Ionis Pharmaceuticals announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases. This collaboration will leverage Ionis'…
Read More...

Cerecor announced that it has agreed to acquire Ichorion Therapeutics, Inc. Ichorion is a privately-held biopharmaceutical company focused on developing treatments and increasing…
Read More...

Propanc Biopharma announced the execution of a research collaboration agreement with the University of Jaén, Spain, for the provision of research services and scientific technical…
Read More...

Sanofi will change the organizational structure of two of its Global Business Units (GBU) to provide greater focus on its operations in mature markets and across emerging markets.…
Read More...

Boehringer Ingelheim announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical company specializing in the development of oncolytic viral therapies.…
Read More...

Cambrex Corporation announced it has completed the acquisition of Halo Pharma (Halo), a leading dosage form Contract Development and Manufacturing Organization (CDMO) located in…
Read More...

Casma Therapeutics announced a research collaboration with Fondazione Telethon, founder of the Telethon Institute of Genetics and Medicine (TIGEM), to develop new therapies for…
Read More...

LEO Pharma and Bayer announced the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States.…
Read More...

Novartis announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo…
Read More...

Sanofi has reached a civil settlement with the U.S. Securities and Exchange Commission (SEC) fully resolving the SEC’s investigation into possible violations of the U.S. Foreign Corrupt…
Read More...

NovellusDx and Primetech announce that Primetech will provide NovellusDx' functional genomics assay "FACT – Functional Annotation for Cancer Treatment" as an exclusive dealer in Japan…
Read More...

Evox Therapeutics Ltd announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the financing with significant new…
Read More...

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company has appointed Arin Maercks as chief commercial…
Read More...

UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on oral solid and semi-solid drug dosage forms, has appointed Dr. Chi-Chang Wung to the…
Read More...

Sirona Biochem Corp. announced that it has received the $500,000 USD milestone payment from partner Wanbang Biopharmaceuticals Co., Ltd for approval by the China Food and Drug…
Read More...

PTC Therapeutics announced that it has successfully completed the acquisition of Agilis Biotherapeutics, Inc., a private biotechnology company focused on the advancement of innovative…
Read More...